Featured

  • Biologics
    Academia the Main Innovation Source for Orthobiologics

    Academia the Main Innovation Source for Orthobiologics

    Smith+Nephew has formed a Biologics and Regenerative Medicine R&D team dedicated to development of innovative orthobiologic products.
    Online Exclusives Michael Barbella, Managing Editor 06.05.20
  • Bracing/Prosthetics
    DJO Releases DonJoy X-ROM Post-Op Knee Brace

    DJO Releases DonJoy X-ROM Post-Op Knee Brace

    Designed for fast, easy application to aid advanced range of motion control and protection.
    Business Wire 06.01.20
  • Biologics
    Surgeon Creativity Shaping Orthobiologics Innovation

    Surgeon Creativity Shaping Orthobiologics Innovation

    Good relationships with surgeon customers can lead to collaborative development efforts.
    Online Exclusives Michael Barbella, Managing Editor 05.29.20
  • Spine/Neurology
    Reducing the Footprint of Spinal Fusion

    Reducing the Footprint of Spinal Fusion

    This interview with Neo Medical’s CEO reveals the firm’s strategy to refresh the view of spinal surgery instrumentation and technology.
    Online Exclusives Sean Fenske, Editor-in-Chief 05.29.20
  • Conventus Orthopaedics Acquires Flower Orthopedics

    Conventus Orthopaedics Acquires Flower Orthopedics

    Flower's Ready-for-Surgery platform reduces exposure to bioburden while enhancing OR efficiencies.
    PR Newswire 05.27.20
  • Coatings/Surface Modification
    On the Surface: Treatments and Coatings for Orthopedics

    On the Surface: Treatments and Coatings for Orthopedics

    Orthopedic device manufacturers are seeking solutions to address osseointegration, anti-bacterial, and product identification challenges.
    Mark Crawford, Contributing Writer 05.20.20
  • MIS/Robotics
    Do Not Disturb: A Look at Minimally Invasive Surgical Technologies

    Do Not Disturb: A Look at Minimally Invasive Surgical Technologies

    Leaving tissues and muscles generally untouched, minimally invasive orthopedic technologies are gaining a strong foothold in joint repair and spinal fusion.
    Michael Barbella, Managing Editor 05.20.20
  • Large Joint | Spine/Neurology
    Built for Comfort & Speed: The Manufacturing of Implants

    Built for Comfort & Speed: The Manufacturing of Implants

    Specializing in orthopedic and spinal implant manufacturing requires the willingness to adapt to the dynamic industries.
    Sam Brusco, Associate Editor 05.20.20
  • Extremities | Large Joint | Spine/Neurology
    Electing a Path Back to Operational Normalcy

    Electing a Path Back to Operational Normalcy

    In deciding whether to allow elective surgeries to resume, states must balance patient needs with safety and equipment requirements.
    Michael Barbella, Managing Editor 05.20.20
  • Illusion of Choice in Orthopedics in a COVID World

    Illusion of Choice in Orthopedics in a COVID World

    The Permanente Medical Groups represent a behemoth compared to the rest of the medical groups in the U.S. Kaiser employs more than three times the number of physicians as the second largest group—Fresenius Medical Care Holdings. The Permanente…
    Maria Shepherd, President and Founder, Medi-Vantage 05.20.20
  • Winning from the Sidelines: What Can We Do Now to Mitigate Pandemic Fallout?

    Winning from the Sidelines: What Can We Do Now to Mitigate Pandemic Fallout?

    Discover a contest to determine the top 10 ideas, technologies, software systems, or other processes that will best serve orthopedic patients.
    Dawn A. Lissy, Founder & President, Empirical 05.20.20
  • Software & Quality
    The 5 Steps Toward Machine Learning

    The 5 Steps Toward Machine Learning

    Many want to use AI/ML applications, but few have the means to do so; the process is a long one, so the best approach is to just take one step at a time.
    Sue Marchant, Director of Product, Machine Learning and Artificial Intelligence, MasterControl 05.20.20
  • Biocompatibility & Testing
    Conducting Chemical Characterization/Risk Assessment for FDA Submissions

    Conducting Chemical Characterization/Risk Assessment for FDA Submissions

    Chemical characterization/risk assessment is a powerful methodology for addressing select biocompatibility endpoints.
    Robert A. Allen, Ph.D., Senior Associate, Regulatory Affairs, MCRA LLC 05.20.20
  • Design
    Design Intent Strategy Brings Clarity to Device Development

    Design Intent Strategy Brings Clarity to Device Development

    Communicating clear design intent is an important indicator for success in medical device development.
    Philip Allen, VP Sales and Marketing, Lowell Inc. 05.20.20
  • COVID Strategy for Regulatory and Quality Professionals and Their Leaders

    COVID Strategy for Regulatory and Quality Professionals and Their Leaders

    Great challenges and changes are being wrought by the SARS-CoV-2 virus and mitigation efforts to control its spread. The changes have been relatively sudden and impact every aspect of personal and professional life. While these changes seem abrupt an…
    Bryan Brosseau, Founder and Principal Consultant, Brosseau Consulting LLC 05.20.20